Andrew J Sauer MD ✓

@AndrewJSauer · Kansas City, MO · joined 11 Jun 2014

Cardiologist @MidAmericaHeart, building programs to implement therapies, advance discovery, and foster innovation for patients suffering from heart disease.

20 321Followers

2 170Following

20 134Posts total

55.7KViews on collected posts

Son gönderiler

Andrew J Sauer MD ✓@AndrewJSauer2 Sep

The argument for studies needing to be finerenone vs “active comparator” falls flat when the so-called active comparator has not been shown to be better than placebo in these populations. The argument makes more sense for ASI vs nsMRA than it does for nsMRA vs sMRA. 5.5K views · 21 likes · 6 reposts · 2 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer2 Sep

@AndrewJSauer @escardio Because ESC interprets MR blockade as a class effect. FINEARTS-HF provides the strongest evidence, while steroidal MRA support comes mainly from TOPCAT/meta-analysis. The Class I is therefore partly extrapolated. https://t.co/Vdn9547iVU 1.3K views · 8 likes · 0 reposts · 0 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer2 Sep

@AndrewJSauer @escardio It is due to the meta-analysis of MRAs presented in London last year, and does not take into account SPIRIT (which is not published yet; we all know its flaws, but it is still evidence) https://t.co/KQyvPz4c47 2.3K views · 6 likes · 0 reposts · 1 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer2 Sep

@AndrewJSauer @escardio Had TOPCAT utilized same PEP as FINEARTS-HF, it would have made the cut. There is no material difference in CV or Kidney outcomes with either Rx. Agree neither trial warrants Class 1 rec for HFpEF unless avoiding HFH is a top priority equal to mortality. 6.9K views · 22 likes · 1 reposts · 1 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer2 Sep

I’m sorry but how does @escardio give MRA (without differentiating sMRA from nsMRA) a Class I for HFpEF? Where is the evidence for steroidal MRA? And even if we base on nsMRA, we have one study (FINEARTS-HF) and we somehow end up with a Class I? Make it make sense. 21.5K views · 131 likes · 15 reposts · 14 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer1 Sep

EP keeps winning on RCT names. SINGLE-AF lol. Well played. 5.4K views · 38 likes · 1 reposts · 3 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer1 Sep

Some solid questions here to consider tbh 4.8K views · 12 likes · 2 reposts · 3 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer6 May

@AndrewJSauer @NMHheartdoc @gcfmd @SJGreene_md @MidAmericaHeart @MichaelNassifMD @BrettSperryMD @RyanTedfordMD @hvanspall @noshreza Love this! 369 views · 2 likes · 0 reposts · 0 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer6 May

It was a privilege to welcome Dr. Clyde Yancy to Kansas City for a city-wide discussion on contemporary medical therapy for heart failure and the evolving challenge of sudden cardiac death risk. Few leaders have had as much influence across the modern eras of heart failure care 7.6K views · 72 likes · 13 reposts · 4 replies Open on X →

Andrew J Sauer MD ✓@AndrewJSauer27 Jun 2021

My top ten tips for graduating fellows and faculty entering and continuing “early career” as I am transitioning into “mid-career”. A thread: 0 views · 1.6K likes · 435 reposts · 95 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 7 gönderi, 10K–100K takipçi aralığıyla yan yana. geniş kitleye gösteriliyor, ama izleyenlerin azı tepki veriyor.

Medyan görüntülenme5 355bu hesap92410K–100K için medyan

Erişim, %26.35%bu hesap3.62%10K–100K için medyan

Etkileşim, %0.52%bu hesap1.52%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	5 355	924	5.80×
Erişim (görüntülenme ÷ takipçi)	26.35%	3.62%	7.28×
Etkileşim oranı	0.52%	1.52%	0.34×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

7.6K6 May

369

4.8K1 Sep

5.4K

21.5K2 Sep

6.9K

2.3K

1.3K

5.5K

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.18%6 May

0.54%

0.35%1 Sep

0.80%

0.77%2 Sep

0.36%

0.30%

0.63%

0.52%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes65.3%312 in total

Reposts7.9%38 in total

Replies5.9%28 in total

Quotes1.7%8 in total

Bookmarks19.2%92 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar